Vas Narasimhan Archives -

Vas Narasimhan

A Swiss newspaper has said Novartis’ previously announced restructuring programme could lead to 8,000 axed jobs, including up

Novartis will shed 7% of workforce in restructuring, say reports

https://pharmaphorum.com/news/novartis-will-shed-7-of-workforce-in-restructuring-say-reports/

Novartis chief executive Vas Narasimhan, already eyeing a possible divestment of generics business Sandoz, has now turned his

CMO John Tsai exits, as Novartis starts revamp that aims to save $1bn

https://pharmaphorum.com/news/cmo-john-tsai-exits-as-novartis-starts-revamp-that-aims-to-save-1bn/

The comprehensive restructuring of Novartis under new CEO Vas Narasimhan resulted in $15 billion in bolt-on acquisitions last

Novartis spent $15bn on M&A last year, with more to come

https://pharmaphorum.com/news/novartis-spent-15bn-on-ma-last-year-with-more-to-come/

Joe Jimenez is to step down after eight years as Novartis chief executive, and will be leaving on

Jimenez to step down as Novartis chief, Narasimhan takes over

https://pharmaphorum.com/news/jimenez-step-novartis-chief-narasimhan-takes/

Novartis is trialling artificial intelligence (AI) in settings across drug discovery and drug development to help its scientists

AI helping us make smarter, faster decisions, says Novartis R&D chief

https://pharmaphorum.com/news/ai-helping-us-says-novartis-rd-chief/

Vas Narasimhan